CHRA vs ILMN

Charah Solutions Inc.

Charah Solutions, Inc. provides environmental services to the power generation industry in the United States. The company offers remediation and compliance services, including environmental management of landfills for coal-fired power generation facilities and new and existing ash ponds; active pond management services, such as closure by removal, cap-in-place, and design and construction of new ponds. Its remediation and compliance services also include landfill development, construction, and management; site evaluation and characterization; preliminary design and cost estimates with life-cycle analysis; hydrogeological assessment; groundwater and containment modeling; permit application and processing for expansions and greenfield sites; design engineering; construction of landfills and cap and cover systems; conversion of impoundments to landfill sites; quality assurance and control, and documentation; engineered fills (off-site); and other related services. In addition, the company recycles recurring and contracted volumes of coal-fired power generation waste byproducts comprising bottom ash, fly ash, and gypsum byproducts for the use in various industrial purposes. Further, it provides coal ash management services; fossil services that include silo management, on-site ash transportation, and capture and disposal of ash byproduct from coal power operations; and manages combustion byproducts comprising bottom ash, as well as disposal of flue gas desulfurization gypsum, Pozatec/fixated scrubber sludge, and fluidized bed combustion fly ash; and environmental risk transfer services that manages the sites' remediation requirements. Charah Solutions, Inc. was founded in 1987 and is headquartered in Louisville, Kentucky.

Illumina Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.